• epilepsy

    New Epilepsy Drug That Lead Patients To Serious problems

    Memory and other cognitive problems are more common among epilepsy patients taking the popular Epilepsy Drug Treatment Topamax than in those taking an older Epilepsy mediation, new research suggests.The findings may have broad implications because Topamax also shows promise in the treatment of obesity, migraines, and even alcoholism.In a study released Friday, researchers in Texas reported that alcoholics taking the Epilepsy Drug Treatment had dramatic reductions in episodes of binge drinking. Another study, reported in February, found the drug to be highly effective in reducing binge eating. Topamax was introduced in 1996 in a wave of new anti-seizure drugs. Its use was quickly associated with numerous cognitive side effects, but it…

  • epilepsy

    Great News!!! New Epileptic Seizure Treatment Wins FDA approval

    Epileptic Seizure Treatment Approved By FDA The U.S. Food and Drug Administration (FDA) has approved Briviact (brivaracetam) for Epileptic Seizure Treatment as an adjunctive therapy (used in addition to a primary therapy) for the Epileptic Seizure Treatment of patients who are at least 16 years old, announced the Belgium-based global biopharma UCB. “The FDA’s approval of Briviact for Epileptic Seizure Treatment is significant, because uncontrolled seizures can have serious, long-term effects, and approximately 30 percent of epilepsy patients remain uncontrolled on currently available treatments,” Dr. Pavel Klein, director of the Mid-Atlantic Epilepsy and Sleep Center, said in a press release.Briviact for Epileptic Seizure Treatment is a new molecular entity that was rationally designed and developed…